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1. Abbreviations 
The following abbreviations are used in the text of the ESI file: anti-parallel (ap), aqueous 
(aq.), argon (Ar), bis(pinacolato)diboron (b(pin)2), closed form (CF), degree of labeling 
(DOL), diarylethene (DE), dichloromethane (DCM), N,N'-dicyclohexylcarbodiimide (DCC), 
2-dicyclohexylphosphino-2′,6′-dimethoxybiphenyl (SPhos), 4-(dimethylamino)pyridine 
(DMAP), dimethylformamide (DMF), dimethylsulfoxide (DMSO), electrospray ionization 
(ESI), ethyl acetate (EtOAc), high performance liquid chromatography (HPLC), high 
resolution mass spectrometry (HR-MS), Matrix-assisted laser desorption/ionization time of 
flight (MALDI-TOF), minutes (min), N-hydroxysuccinimide (NHS), nuclear magnetic 
resonance (NMR), open form (OF), parallel (p), phosphate buffer saline (PBS), potassium 
acetate (KOAc), reverse phase (RP), room temperature (r.t.), tetrahydrofuran (THF), 
triethylamine (TEA), trifluoroacetic acid (TFA), thin layer chromatography (TLC), ultra-
violet (UV), visible (vis). 
2. General remarks 
2.1 Chemicals and reagents 
Flash column chromatography was performed using cartridges from Interchim (PF-SIHC, 15 
μM, 25 g or 40 g SiO2) or Teledyne Isco (RediSep®Rf, 35 μM, 24 g or 40 g SiO2). Analytical 
TLC was performed on Merck Millipore ready-to-use plates with silica gel 60 (F254). The 
spots were visualized by illumination with a UV lamp (λ = 254 and 365 nm) and/or staining 
with aq. KMnO4 solution. Anhydrous DMF were purchased from Sigma-Aldrich and stored 
over 4 Å molecular sieves. HPLC gradient-grade acetonitrile (CH3CN) was obtained from 
Sigma-Aldrich. Aqueous buffers (PBS (pH 6.5) and NaHCO3 (pH 8.3) used for the 
preparation of bioconjugates and in the fluorescence assay) and mobile phases for HPLC were 
prepared with water purified by means of an ELGA system. Unless stated otherwise, all 
chemicals were used as received from commercial sources without further purification. The 
following starting material were synthesized according to literature procedures: 1,2-bis(2-
ethyl-6-iodobenz[a]thiophen-1,1-dioxide-3-yl)perfluorocyclo-pentene[1], 3,5-di(tert-
butoxycarbonylphenyl)boronic acid pinacol ester[2] and tert-butyl iminodiacetate.[3] 3,5-
dicarboxyphenylboronic acid pinacol ester,  5-boronoisophtalic acid  and 3,5-
diformylphenylboronic acid were respectively purchased from Fluorochem, Apollo Scientific 
and Sigma Aldrich. Secondary antibodies (AffiniPure Sheep Anti-Mouse IgG (H+L)) were 
obtained from Jackson ImmunoResearch Laboratories, Inc. PD-10 desalting columns used for 
the isolation of the conjugates with antibodies were purchased from GE Healthcare Europe 
GmbH.  
2.2 Instruments and methods 
1H, 19F and 13C NMR spectra were recorded at 25 °C on an Agilent 400-MR or 500-MR 
spectrometer. Chemical shifts are given in parts per million (ppm) using the residual solvent 
peak(s) as a reference.[4] Multiplicities of the signals are described as follows: s = singlet, d = 
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doublet, t = triplet, q = quartet, m = multiplet or overlap of non-equivalent resonances. J 
values are expressed in Hz. The NMR spectra of hydrophilic diarylethenes 1 and 2 were 
recorded in DMF-d7 due to poor solubility of these dyes in common solvents and their 
reaction with DMSO-d6 and traces of water in it (leading to a compound with a -CF2CF2CO- 
fragment instead of the initial -(CF2)3- bridge; an analog of the transformation observed in the 
oxidation according to Swern). Each diarylethene derivatives 1, 2, 5, 6 and 7 presented in this 
article was obtained as a mixture of three forms (two open forms (OF): anti-parallel (ap) and 
parallel (p); and the closed isomer (CF)). These isomers could be detected separately by NMR 
spectroscopy. The anti-parallel (ap) and parallel (p) forms of the “open” isomers gave one 
peak in HPLC (and could not be isolated separately due to rapid interconversion). We 
managed to isolate both closed isomers of 1 and 2 after irradiation at 365 nm (see 
experimental procedure in section 3 and NMR spectra in section 6). Analytical and 
preparative RP-HPLC were carried out with a Knauer Smartline system equipped with a 
Dionex Ultimate 3000 detector. Automated flash purifications on regular silica gel and 
reversed phase (RP-C18) cartridges were performed with a Biotage Isolera One device. Mass-
spectra with electro-spray ionization (ESI-MS) were recorded on a Varian 500-MS 
spectrometer (Agilent). High-resolution ESI-MS (ESI-HRMS) were recorded on a 
MICROTOF spectrometer (Bruker) equipped with an Apollo ion source and a direct injector 
with an LC-autosampler Agilent RR 1200. MALDI-TOF measurement were performed using 
an autoflex speed mass spectrometer (Bruker) and sinapinic acid as a matrix. The absorption 
spectra were recorded on a Varian Cary 4000 UV-Vis spectrophotometer. The emission 
spectra were recorded on a Varian Cary Eclipse fluorescence spectrophotometer. The relative 
fluorescence quantum yields were measured at 25 °C using fluorescein in NaOH (0.1 M) as 
the reference fluorescent dye with emission efficiency of 0.79. 
Determination of the quantum efficiencies of the isomerization reactions were performed in 
a home-made setup. Irradiation was performed in 1 cm path quartz cuvettes under continuous 
stirring, using LEDs at 365 ± 4 nm and 470 ± 12 nm (Thorlabs) as irradiation sources. The 
intensities of the irradiation light were determined using Azobenzene in methanol (365 nm) 
and Aberchrome 670 in toluene (470 nm), as chemical actinometers. Absorption and emission 
of the solutions were monitored after each short irradiation step until the photostationary state 
was reached. Data analysis was performed as described in detail on pages 12-14 of Supporting 
Information to ref. [3] in the main text (http://www.wiley-vch.de/contents/jc_2002/2006/ 
z602591_s.pdf). 
2.3 High-performance liquid chromatography separations 
Several columns and solvent systems were used for the analytical and preparative HPLC 
separations. System A: RP-HPLC (Kinetec C18 100 column, 5 μm, 4.6250 mm) with 
CH3CN and 0.05% aqueous trifluoroacetic acid (0.05% aq. TFA, pH ~ 2.0) as eluents [linear 
gradient from 40 % to 100% of CH3CN in 20 min] at a flow rate of 1.2 mL/min; UV-vis 
detection with diode array and at 254 nm and 450 nm. System B: see System A; linear 
gradient from 30% to 100% of CH3CN in 20 min. System C: preparative RP-HPLC (Kinetec 
C18 100 column, 5 μm, 20250 mm) with a linear gradient from 60% to 80% of CH3CN in 20 
min at a flow rate of 10 mL/min and detection at 254 nm. System D: automated flash 
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purification on Biotage Isolera One (ISO-1EW) device (cartridge PF-C18-HC, 30 μM, with 20 
g of RP silica gel) with the following eluent: 0.05% aq. TFA / CH3CN, 3:2, at a flow rate of 
20 mL/min for 15 min; UV detection at 254 nm. System E: see System C; linear gradient 
from 35% to 65% of CH3CN in 20 min, dual detection at 254 nm (for detection of OF) and 
450 nm (for detection of CF). System F: see System C; linear gradient from 50% to 75% of 
CH3CN in 15 min, dual detection at 254 nm and 450 nm. 
3. Synthesis 
3.1 Peparation of boronic esters 
 
Scheme S1. Preparation of 3,5-disubstituted phenyl boronates. 
Tetra-tert-butyl 5-bromobenzene-1,3-bis-(N-iminodiacetate) (3) 
 
To a solution of 5-bromoisophtalic acid (610 mg, 4.1 mmol), SOCl2 (3 mL, 40.1 mmol, 10 
equiv.) and few drops of DMF were added, and the reaction mixture was refluxed overnight 
with stirring. An excess of thionyl chloride was removed by distillation, the residue co-
evaporated twice with DCM was used directly in the next step. This acyl chloride was 
dissolved in 35 mL of dry DCM, and a solution of TEA (1.65 mL, 12.2 mmol, 3 equiv.) and 
tert-butyl iminodiacetate[3] (2.1 g, 8.6 mmol, 2.1 equiv.) was added dropwise at 0 °C. After 
stirring overnight at r.t., the mixture was filtered, the filtrate was washed thrice with a 
saturated aq. solution of NaHCO3 (335 mL), dried over MgSO4, concentrated under reduced 
pressure and subjected to flash chromatography on silica gel (n-hexane/EtOAc, with a 
gradient from 100:0 to 80:20). Compound 3 was isolated as a white solid (1.74 g, 61% yield). 
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Rf (n-hexane/EtOAc, 4:1, v/v) = 0.42. 1H NMR (400 MHz, CDCl3): δ = 7.64 (dd, J = 1.5 Hz, 
0.7 Hz, 2 H), 7.43 (t, J = 1.4 Hz, 1 H), 4.15 (s, 4 H), 3.90 (s, 4 H), 1.48 (s, 18 H), 1.45 (s, 18 
H). 13C NMR (101 MHz, CDCl3): δ = 169.7, 168.1, 167.7, 137.7, 131.4, 123.7, 123.1, 83.2, 
82.4, 52.5, 48.5, 28.2, 28.1. ESI-MS, positive mode: m/z (rel. int., %) = 721.4 (100) [M+Na, 
79Br]+ , 723.4 (100) [M+Na, 81Br]+ (found), 722.6 (calculated for C32H47BrN2NaO10, [M+Na, 
81Br]+). 
Tetra-tert-butyl benzeneboronic acid pinacol ester 3,5-bis-(N-iminodiacetate) (4)
  
 
From tetra-tert-butyl 5-bromobenzene-1,3-bis-(N-iminodiacetate) (3) 
In a sealed tube purged with Ar, compound 3 (200 mg, 0.29 mmol), bis-pinacolatodiboron 
(b(pin)2; 87 mg, 0.34 mmol, 1.2 equiv.), KOAc (84 mg, 0.86 mmol, 3 equiv.), PdCl2(dppf) (7 
mg, 8.6 μmol, 0.03 equiv.) was combined, and dry 1,4-dioxan (4 mL) was added. The reaction 
mixture was purged with Ar for further 5 min (Ar bubbling) and stirred at reflux (bath temp. 
120 °C) for 4 h. After removal of volatile materials in vacuum, EtOAc (30 mL) was added, 
and the reaction mixture was washed with brine (230 mL), dried over Na2SO4, concentrated 
under reduced pressure and subjected to column chromatography on silica gel (n-
hexane/EtOAc, with a gradient from 95:5 to 50:50) to afford compound 4 as a white solid (80 
mg, 37% yield).  
From 3,5-dicarboxyphenylboronic acid, pinacol ester  
The synthesis of aromatic acyl chloride (route B in Scheme 1) was performed according to the 
published procedure.[5] A suspension of 3,5-dicarboxyphenylboronic acid, pinacol ester (200 
mg, 0.69 mmol, Fluorochem) in 20 mL of dry DCM was treated with dry DMF (≈ 20 μL) and 
cooled at 0 °C. Then, oxalyl chloride (294 μL, 3.4 mmol, 5 equiv.) was added dropwise, and 
the reaction mixture was refluxed for 6 h. After concentration in vacuum, the acyl chloride 
was dissolved in dry DCM (20 mL), and a solution of TEA (475 μL, 3.4 mmol, 5 equiv.) and 
tert-butyl iminodiacetate[3] (352 mg, 1.44 mmol, 2.1 equiv.) was added dropwise at 0 °C 
under Ar. After stirring overnight at r.t., the reaction mixture was washed with brine (325 
mL), dried over MgSO4, concentrated in vacuum and purified by flash chromatography on 
silica gel (n-hexane/EtOAc, with a gradient from 95:5 to 50:50) to afford compound 4 as a 
white solid (164 mg, 32% yield). Rf (n-hexane/EtOAc, 4:1, v/v) = 0.35. 1H NMR (400 MHz, 
CDCl3): δ = 7.92 (d, J = 1.7 Hz, 2 H), 7.57 (t, J = 1.7 Hz, 1 H), 4.17 (s, 4 H), 3.93 (s, 4 H), 
1.49 (s, 18 H), 1.46 (s, 18 H), 1.28 (s, 12 H). 13C NMR (101 MHz, CDCl3): δ = 171.4, 168.3, 
168.0, 135.3, 134.5, 127.7, 84.3, 82.9, 82.1, 52.5, 48.4, 28.3, 28.2, 24.9. ESI-MS, positive 
mode: m/z (rel. int., %) = 769.6 (100) [M+Na]+ (found), 769.7 (calculated for 
C38H59BN2NaO12, [M+Na]+). 
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3.2 Diarylethene derivatives – “tetra-acid” 1 and “octa-acid” 2 
 
Scheme S2. Syntheses of “tetra-acid” 1 
“Tetra-aldehyde” (5) 
 
A suspension of Pd2(dba)3/P(tBu)3*HBF4 (1:1.2, 74 mg, 61.5 μmol of Pd2(dba)3, 10 mol %), 
3,5-diformylphenylboronic acid (Sigma Aldrich, 241 mg, 1.4 mmol, 2.2 equiv), and KF·2H2O 
(382 mg, 4.1 mmol, 6.6 equiv.) in 10 ml of THF was purged with Ar for 3 min (Ar 
“bubbling”). Then 1,2-bis(2-ethyl-6-iodobenz[a]thiophen-1,1-dioxide-3-
yl)perfluorocyclopentene[1] (500 mg, 0.62 mmol) was added, and the reaction mixture stirred 
at r.t. for 1 h. Then, the crude mixture was diluted with Et2O (2 mL), filtered through a plug of 
silica gel and washed with Et2O (250 mL). The filtrate was concentrated, and the residue 
was purified by flash chromatography on silica gel (n-hexane/EtOAc, with a gradient from 
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95:5 to 35:65) to afford compound 5 as a yellow solid (163 mg, 32% yield). Rf (n-
hexane/EtOAc, 3:2, v/v) = 0.24. ap:p = 60:40. 1H NMR (400 MHz, CDCl3): δ = 10.23 (s, 0.2 
H, p), 10.22 (s, 0.5 H, ap), 10.20 (s, 2 H, ap), 10.16 (s, 1.3 H, p), 8.45 (t, J = 1.5 Hz, 1.2 H, 
ap), 8.40 (t, J = 1.5 Hz, 0.8 H, p), 8.37 (d, J = 1.5 Hz, 2.4 H, ap), 8.29 (d, J = 1.5 Hz, 1.6 H, 
p), 8.06 (d, J = 1.6 Hz, 1.2 H, ap), 8.01 (d, J = 1.6 Hz, 0.8 H, p), 7.92 (dd, J = 8.0 Hz, 1.7 Hz, 
1.2 H, ap), 7.76 (dd, J = 8.0 Hz, 1.7 Hz, 0.8 H, p), 7.34 (d, J = 7.9 Hz, 1.2 H, ap), 7.30 (d, J = 
7.9 Hz, 0.8 H, p), 2.65 (m, 2.8 H, p/ap), 2.50 (m, 1.2 H, p), 1.45 (t, J = 7.6 Hz, 2.4 H, p), 1.17 
(t, J = 7.6 Hz, 3.6 H, ap). 13C NMR (126 MHz, CDCl3): δ = 192.6 p, 192.4 ap, 192.4 p, 192.3 
ap, 149.9 p, 149.6 ap, 142.0 ap, 141.8 p, 139.9 ap, 139.8 p, 138.5 p, 138.4 p/ap, 138.3 p, 
136.9 ap, 136.7 p, 134.1 ap, 134.0 p, 133.9 p, 133.7 ap, 133.6 p, 129.4 p, 129.2 ap, 129.1 ap, 
129.0 p, 125.4 p, 125.2 ap, 123.1 p/ap, 121.5 ap, 121.4 p, 19.4 p, 19.3 ap, 12.0 p, 11.8 ap. 19F 
NMR (376 MHz, CDCl3): δ = 109.76 (t, J = 5.0 Hz, 1.15 F, ap), 109.81 (t, J = 4.6 Hz, 1.15 
F, ap), 109.88 (t, J = 5.8 Hz, 1.7 F, p), 132.04 (m, 1.6 F, p/ap), 132.26 (m, 0.4 F, p). HR-
MS (ESI, positive mode): 847.0852 [M+Na]+ (found), 847.0865 (calculated for 
C41H26F6NaO8S2, [M+Na]+).  
“Tetra-tert-butyl ester” (6) 
 
To a solution of 1,2-bis(2-ethyl-6-iodobenz[a]thiophen-1,1-dioxide-3-
yl)perfluorocyclopentene[1] (50 mg, 61.6 μmol) in a mixture of THF/H2O (4 mL, 3:1, v/v), 
3,5-di(tert-butycarboxyphenyl)boronic acid, pinacol ester[2] (52 mg, 0.13 mmol, 2.1 equiv.), 
K3PO4 (40 mg, 0.19 mmol, 3 equiv.), SPhos (1.5 mg, 3.7 μmol, 6 mol %) and Pd(dba)2 (1.1 
mg, 1.9 μmol, 3 mol %) were added. The suspension was purged for 5 min with Ar (Ar 
“bubbling”) and stirred 4 h at reflux (≈ 80 °C). Then, the mixture was diluted in EtOAc (15 
mL), washed with brine, dried over Na2SO4 and concentrated in vacuum. The residue was 
separated by flash chromatography on silica gel (n-hexane/EtOAc, with a gradient from 100:0 
to 90:10) to afford compound 6 as an yellow solid (35 mg, 51% yield). Rf (n-hexane/EtOAc, 
9:1, v/v) = 0.30. ap:p = 55:45. 1H NMR (400 MHz, CDCl3): δ = 8.63 (t, J = 1.5 Hz, 1.1 H, 
ap), 8.57 (t, J = 1.5 Hz, 0.9 H, p), 8.35 (d, J = 1.5 Hz, 2.2 H, ap), 8.27 (d, J = 1.5 Hz, 1.8 H, 
p), 8.03 (d, J = 1.5 Hz, 1.1 H, ap), 7.97 (d, J = 1.5 Hz, 0.9 H, p), 7.89 (dd, J = 8.0, 1.7 Hz, 1.1 
H, ap), 7.73 (dd, J = 8.0, 1.7 Hz, 0.9 H, p), 7.31 (d, J = 8.0 Hz, 1.1 H, ap), 7.26 (t, J = 4.0 Hz, 
0.9 H, p), 2.63 (m, 2.9 H, ap/p), 2.45 (m, 1.1 H, p), 1.64 (s, 21 H, ap/p), 1.60 (s, 15 H, ap/p), 
1.44 (t, J = 7.6 Hz, 2.7 H, p), 1.12 (t, J = 7.6 Hz, 3.3 H, ap). 13C NMR (101 MHz, CDCl3): δ 
= 164.6 ap, 164.6 p, 149.2 p, 148.8 ap, 142.8 ap, 142.8 p, 140.2 ap/p, 138.4 ap, 138.4 p, 
136.8 ap, 136.8 p, 133.6 ap, 133.5 p, 132.5 ap, 132.3 p, 131.6 ap, 131.6 p, 130.8 ap, 130.8 p, 
128.9 ap, 128.8 p, 123.4 ap/p, 123.2 ap, 123.1 p, 123.0 ap/p, 121.3 p, 121.3 ap, 82.4 ap, 82.3 
p, 28.3 ap, 28.3 p, 19.5 p, 18.4 ap, 12.0 p, 11.8 ap.19F NMR (376 MHz, CDCl3): δ = -109.80 
(t, J = 4.9 Hz, 2.3 F, ap/p), -109.98 (t, J = 4.9 Hz, 1.7 F, ap/p), -132.05 (t, J = 4.8 Hz, 0.4 F, 
p), -132.11 (t, J = 4.7 Hz, 1.2 F, ap), -132.27 (t, J = 4.9 Hz, 0.4 F, p). ESI-MS, negative mode: 
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From compound 5 
To a solution of compound 5 (135 mg, 0.16 mmol) in 90 mL of acetone, Jones reagent (1.64 
mL, 3.27 mmol, 2 M solution in aq. H2SO4, 21 equiv.) was added dropwise at 0 °C; the 
reaction mixture was stirred for 30 min and then allowed to warm to r.t. After removal of 
volatile materials, the residue was taken in EtOAc, washed successively with H2O and 
saturated aq. NaCl solution, dried over Na2SO4, and concentrated in vacuum. Then the crude 
mixture was purified by flash chromatography on silica gel (n-hexane/EtOAc + 5% HCO2H, 
with a gradient from 95:5 to 0:100) to afford compound 1 as an orange-yellow solid (106 mg, 
73% yield).  
From compound 6 
Compound 6 (35 mg, 31.4 μmol) was dissolved in a mixture of TFA/DCM (5 mL, 1:1, v/v) 
and stirred for 1 h at reflux. Then the reaction mixture was concentrated in vacuum and 
subjected to flash chromatography using a RP-C18 cartridge (system D). The product-
containing fractions were pooled and lyophilized to give compound 6 as an amorphous yellow 
solid (7 mg, 25% yield). 
From 5-boronoisophtalic acid 
To a solution of 1,2-bis(2-ethyl-6-iodobenz[a]thiophen-1,1-dioxide-3-yl)perfluoro-
cyclopentene[1] (50 mg, 61.6 μmol) in a mixture of EtOH/H2O (8 mL, 1:1, v/v), 5-
boronoisophtalic acid (Apollo Scientific, 27 mg, 0.13 mmol, 2.1 equiv.), K3PO4 (40 mg, 0.19 
mmol, 3 equiv.), SPhos (1.5 mg, 3.7 μmol, 6 mol %) and Pd(dba)2 (1.1 mg, 1.9 μmol, 3 mol 
%) were added. The suspension was purged for 5 min with Ar (Ar “bubbling”) and stirred 
overnight at reflux (≈ 80 °C). Then, the mixture was concentrated in vacuum, and the residue 
was separated by flash chromatography on silica gel (n-hexane/EtOAc + 5% HCO2H, with a 
gradient from 95:5 to 0:100) to afford compound 1 as an orange-yellow solid (25 mg, 46% 
yield). Rf (n-hexane/EtOAc + 5% HCOOH, 1:4, v/v) = 0.28. ap:p = 60:40. 1H NMR (500 
MHz, CDCl3/CF3COOD): δ = 8.89 (t, J = 1.5 Hz, 1.2 H, ap), 8.84 (t, J = 1.5 Hz, 0.8 H, p), 
8.62 (d, J = 1.6 Hz, 2.4 H, ap), 8.51 (d, J = 1.6 Hz, 1.6 H, p), 8.12 (d, J = 1.7 Hz, 1.2 H, ap), 
8.06 (d, 0.8 H, p), 7.96 (dd, J = 8.1 Hz, 1.7 Hz, 1.2 H, ap), 7.78 (dd, J = 8.0 Hz, 1.7 Hz, 0.8 H, 
p), 7.4 (d, J = 8.0 Hz, 1.2 H, ap), 7.33 (d, J = 8.0 Hz, 0.8 H, p), 2.60 (m, 2.7 H, p/ap), 2.49 (m, 
1.3 H, p), 1.45 (t, J = 7.5 Hz, 2.3 H, p), 1.15 (t, J = 7.6 Hz, 3.6 H, ap). 13C NMR (126 MHz, 
CDCl3/CF3COOD): δ = 170.8 ap, 170.7 p, 149.4 ap, 148.8 p, 141.8 ap, 141.7 p, 139.7 ap, 
139.6 p, 136.6 p, 136.5 ap, 134.3 ap, 134.2 p, 133.1 ap, 132.6 p, 132.6 ap, 132.5 p, 130.6 ap, 
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130.5 p, 129.5 p, 129.5 ap, 125.0 p/ap, 123.9 p, 123.8 ap, 123.7 p, 123.5 ap, 121.7 p/ap, 19.6 
p, 19.4 ap, 12.0 p, 11.8 ap (2 carbons are masked by solvent peaks). 19F NMR (471 MHz, 
CDCl3): δ = -109.86 (t, J = 4.5 Hz, 2.6 F, ap), -109.98 (t, J = 4.5 Hz, 0.7 F, p), -110.11 (t, J = 
4.5 Hz, 0.7 F, p), -132.03 (m, 0.4 F, p), -132.19 (q, J = 4.5 Hz, 1.2 F, ap), -132.34 (m, 0.4 F, 
p). HR-MS (ESI, negative mode): 887.0698 [M-H]- (found), 887.0697 (calculated for 
C41H25F6O12S2, [M-H]-). HPLC (system A): tR = 9.7 min (closed form) and 10.0 min (open 
form). 
 
Scheme S3. The synthesis of “octa-acid” 2  
“Octa-acid” tert-butyl ester (7) 
 
To a solution of 1,2-bis(2-ethyl-6-iodobenz[a]thiophen-1,1-dioxide-3-yl)perfluorocyclo-
pentene[1] (80 mg, 0.099 mmol) in a mixture of THF/H2O (4 mL, 3:1, v/v), arylboronic ester 4 
(154 mg, 0.21 mmol, 2.1 equiv.), K3PO4 (63 mg, 0.30 mmol, 3 equiv.), SPhos (2.4 mg, 6 
mol, 6 mol %) and Pd(dba)2 (1.7 mg, 3 mol, 3 mol %) were added; the suspension was 
purged for 5 min with Ar (Ar “bubbling”) and stirred 4 h at reflux. Then, the reaction mixture 
was diluted with EtOAc, washed with brine (325 mL), dried over Na2SO4 and concentrated. 
The residue was purified by flash chromatography on silica gel (n-hexane/EtOAc, with a 
gradient from 95:5 to 50:50) to afford compound 7 as a yellow solid (102 mg, 58% yield). Rf 
(n-hexane/EtOAc, 7:3, v/v) = 0.32. ap:p = 80:20. 1H NMR (500 MHz, CDCl3): δ = 7.96 (d, J 
= 1.7 Hz, 1.6 H, ap), 7.89 (d, J = 1.7 Hz, 0.4 H, p), 7.83 (dd, J = 8.0, 1.7 Hz, 1.6 H, ap), 7.78 
(d, J = 1.5 Hz, 3.2 H, ap), 7.71 (m, 1.2 H, p/ap), 7.57 (t, J = 1.4 Hz, 1.6 H, ap), 7.52 (t, J = 1.5 
Hz, 0.4 H, p), 7.29 (d, J = 8.0 Hz, 1.6 H, ap), 7.20 (d, J = 8.0 Hz, 0.4 H, p), 4.24 (s, 0.7 H, 
p/ap), 4.21 (s, 2.5 H, p/ap), 4.18 (s, 2.6 H, p/ap), 4.15 (s, 1.7 H, p/ap), 4.14 (s, 0.8 H, p/ap), 
3.95 (s, 6 H, p/ap), 3.91 (s, 1.7 H, p/ap), 2.58 (m, 2.4 H, p/ap), 2.35 (m, 1.6H, p), 1.50 (s, 14.4 
H, ap), 1.50 (t, 1.4 H, p, masked by previous peak), 1.48 (s, 3.6 H, p), 1.38 (s, 14.4 H, ap), 
1.33 (s, 3.6 H, p), 1.23 (s, 36 H, p/ap), 1.04 (t, J = 7.6 Hz, 4.6 H, ap). 13C NMR (126 MHz, 
CDCl3): δ = 170.6 ap, 170.5 p, 168.3 p/ap, 167.8 p/ap, 149.5 p, 149.1 ap, 142.2 p/ap, 139.0 p, 
138.9 ap, 137.2 ap, 137.1 p, 137.0 ap, 136.9 p, 132.4 ap, 132.3 p, 129.2 ap, 128.9 p, 127.2 p, 
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127.1 ap, 125.4 p, 125.4 ap, 123.5 p/ap, 123.0 ap, 122.9 p, 121.1 p, 120.9 ap, 83.3 ap, 83.1 p, 
82.4 ap, 82.3 p, 75.2 p/ap, 52.6 p/ap, 48.6 p/ap, 28.3 p/ap, 28.1 ap, 28.0 p, 25.0 p/ap, 19.5 p, 
19.2 ap, 12.0 p, 11.8 ap. 19F NMR (376 MHz, CDCl3): δ = -109.78 (t, J = 5.4 Hz, 1.6 F, p/ap), 
-109.85 (t, J = 5.3 Hz, 1.6 F, p/ap), -110.03 (t, J = 5.8 Hz, 0.8 F, p/ap), -132.19 (m, 2F, p/ap). 
ESI-MS, positive mode: m/z (rel. int., %) = 1796.3 (100) [M+H]+ (found), 1797.0 (calculated 
for C89H109F6N4O24S2, [M+H]+).  
“Octa-acid” (2) 
 
Compound 7 (102 mg, 57.8 μmol) was dissolved in a mixture of TFA/DCM (20 mL, 1:1, v/v) 
and stirred for 1 h at reflux. Then the reaction mixture was concentrated in vacuum and 
subjected to flash chromatography using a RP-C18 cartridge (system D). The product-
containing fractions were pooled and lyophilized to give compound 2 as an amorphous yellow 
solid (54 mg, 71% yield). ap:p = 65:35. 1H NMR (500 MHz, DMF-d7): δ = 8.48 (d, J = 1.7 
Hz, 1.3 H, ap), 8.38 (d, J = 1.7 Hz, 0.7 H, p), 8.23 (dd, J = 8.1, 1.8 Hz, 1.3 H, ap), 8.09 (dd, J 
= 8.1 Hz, 1.8 Hz, 0.7 H, p), 7.97 (d, J = 1.5 Hz, 2.4 H, ap), 7.92 (d, J = 8.1 Hz, 0.7 H, p), 7.88 
(m, 2.7 H, p/ap), 7.55 (t, J = 1.5 Hz, 1.3 H, ap), 7.48 (t, J = 1.5 Hz, 0.8 H, p), 4.36 (s, 5.2 H, 
ap), 4.32 (s, 2.8 H, p), 4.30 (s, 5.2 H, ap), 4.24 (s, 2.8 H, p), 2.75 (m, 2 H, p/ap, masked 
partially by NMR solvent), 2.60 (m, 2 H, p), 1.42 (t, J = 7.6 Hz, 2.1 H, p), 1.03 (t, J = 7.6 Hz, 
3.9 H, ap). 13C NMR (126 MHz, DMF-d7): δ = 171.6 p, 171.4 ap, 170.8 ap, 170.7 p, 170.6 
p/ap, 149.6 p, 149.5 ap, 142.5 ap, 142.3 p, 138.8 ap, 138.5 p, 137.6 ap, 137.4 p, 136.7 ap, 
136.5 p, 133.8 ap, 133.4 p, 128.8 ap, 128.5 p, 126.8 ap, 126.7 p, 125.7 p/ap, 125.0 p/ap, 
123.1 p/ap, 121.2 ap, 121.0 p, 52.2 p, 52.1 ap, 48.4 p, 48.3 ap, 19.3 p, 19.1 ap, 11.9 p, 11.6 
ap. 19F NMR (376 MHz, DMF-d7): δ = -110.82 (m, 2.7 F, p/ap), -110.98 (m, 1.3 F, p), -
130.84 (m, 2 F, p/ap). HR-MS (ESI, negative mode): 673.0833 [M-2H]2- (found), 673.0851 
(calculated for C57H45F6N4O24S2, [M-2H]2-). HPLC (system B): tR = 6.0 min (closed form) 
and 7.5 (open form). 
Preparation of pure closed isomer (1-CF) 
 
A solution of compound 1-OF (2 mg, 2.25 µmol) in CH3CN (4 mL) was placed into a quartz 
cuvette for photolysis. Then the middle-pressure mercury lamp (150 W) was turned on, and 
the solution was irradiated at rt with stirring for 45 min, until compound 1-OF was fully 
converted in compound 1-CF (checked for completion by RP-HPLC). The solvent was 
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removed in vacuo and the residue was isolated by semi-preparative HPLC (system F). The 
product-containing fractions were pooled and lyophilized to give compound 1-CF as an 
amorphous yellow solid (0.4 mg, 20% yield). 1H NMR (500 MHz, DMF-d7): δ = 8.64 (s, 2 
H), 8.52 (dd, J = 8.7, 1.6 Hz, 2 H), 8.41 (d, J = 8.3 Hz, 2 H), 8.12 (d, J = 1.3 Hz, 4 H), 7.61 (s, 
2 H), 4.37 (s, 8 H), 4.30 (s, 8 H), 2.45 (m, 4 H), 0.67 (t, J = 7.4 Hz, 6 H). 8.80 (t, J = 1.5 Hz, 
1H), 8.72 (d, J = 1.5 Hz, 1H), 8.70 (d, J = 1.4 Hz, 2H), 8.60 (dd, J = 8.7, 1.8 Hz, 1H), 8.47 (d, 
J = 8.3 Hz, 1H), 2.53 – 2.40 (m, 2H), 0.69 (t, J = 7.4 Hz, 3H). 
Preparation of pure closed isomer (2-CF) 
 
A solution of compound 2-OF (2 mg, 1.48 µmol) in CH3CN (4 mL) was placed into a quartz 
cuvette for photolysis. Then the middle-pressure mercury lamp (150 W) was turned on, and 
the solution was irradiated at rt with stirring for 45 min, until compound 2-OF was fully 
converted in compound 2-CF (checked for completion by RP-HPLC). The solvent was 
removed in vacuo and the residue was isolated by semi-preparative HPLC (system E). The 
product-containing fractions were pooled and lyophilized to give compound 2-CF as an 
amorphous yellow solid (0.6 mg, 30% yield). 1H NMR (500 MHz, DMF-d7): δ = 8.64 (s, 2 
H), 8.52 (dd, J = 8.7, 1.6 Hz, 2 H), 8.41 (d, J = 8.3 Hz, 2 H), 8.12 (d, J = 1.3 Hz, 4 H), 7.61 (s, 
2 H), 4.37 (s, 8 H), 4.30 (s, 8 H), 2.45 (m, 4 H), 0.67 (t, J = 7.4 Hz, 6 H). 
3.3 Conjugation of “tetra-“ and “octa-acids” 1a,b with antibodies 
Preparation of NHS ester from “Tetra-acid” (8) followed by conjugation with 
antibodies (IgG) 
(a) Synthesis of mono NHS ester (8) 
 
To a solution of 1 (10 mg, 11.3 μmol) in 200 μL of dry DMF, NHS (15.6 μL of a stock 
solution in DMF; c = 0.87 M, 13.6 μmol, 1.2 equiv.), DMAP (8.3 μL of a stock solution in 
DMF; c = 0.16 M, 1.4 μmol, 0.1 equiv.) and DCC (14 μL of a stock solution in DMF; c = 
0.97 M, 13.6 μmol, 1.2 equiv.) were added, and the reaction mixture was stirred at r.t. for 2 h. 
The course of the reaction was monitored by HPLC. Additional amounts of NHS (6.5 μL, 5.7 
μmol, 0.5 equiv.) and DCC (5.8 μL, 5.7 μmol, 0.5 equiv.) were added, and stirring was 
continued overnight. Then the reaction was “quenched” by adding acetic acid (5 μL). The 
solution was concentrated in vacuum, in order to remove DMF, and the products were 
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isolated by preparative HPLC (system C). The fractions containing compound 8 were 
lyophilized to give a yellow amorphous solid (2 mg, 18% yield). ESI-MS, negative mode: m/z 
(rel.int., %) = 984.6 (100) [M-H]- (found), 984.8 (calculated for C45H28F6NO14S2, [M-H]-). 
HPLC (system B): tR = 12.8 min (closed form) and 13.0 (open form). 
(b) Antibody labeling 
A solution of mono NHS ester 8 (0.2 mg or 0.1 mg in 40 μL DMF) was added dropwise to a 
stirred solution of the secondary antibodies (2 mg in 1 mL of NaHCO3 buffer; pH 8.3). The 
reaction mixture was protected from light and stirred at r.t. for 1 h. Then the solution was 
applied onto a Sephadex G-25 column (PD-10) pre-equilibrated with the elution buffer (PBS 
pH 6.5). Fractions of ca. 0.5 mL were collected, and the protein-content in each of them was 
evaluated by absorption spectroscopy and Bradford assay. The bioconjugate eluted with the 
front, with typical recovery efficiencies and dilution factors of ca. 90% and 1.5, respectively 
(calculated from UV-Vis spectroscopy measurements). Free (non-conjugated) diarylethene 
stays in the column and does not elute with protein.  
In situ activation of the “octa-acid” 2 followed by conjugation with antibodies 
(IgG) 
To a DMF solution of “octacid” 2 (0.2 mg, 0.1 mg, or 0.05 mg, in 50 μL DMF), NHS (1.4 
equiv.) and EDC (10 equiv.) were added as stock solutions in DMF, and the reaction mixture 
was stirred at r.t. for 1 h. Then the reaction mixture containing the activated “octa-acid” 2 was 
added dropwise to the stirred solution of the secondary antibody (2 mg in 1 mL of NaHCO3 
buffer at pH = 8.3), protected from light and stirred at r.t. for 1 h. Then, the resulting mixture 
was purified by a sephadex column pre-equilibrated with PBS buffer (pH 6.5) and eluted with 
the same buffer (unlabeled DE and DE-bioconjugate are closely eluted). Fractions of ca. 0.5 
mL were collected, and the protein-content in each of them was evaluated by absorption 
spectroscopy and Bradford assay. 
Determination of the degrees of labeling of the bioconjugates 
The degrees of labeling (DOL) of the different bioconjugates prepared were determined 
independently by two methods, optical spectroscopy (UV-vis absorption) and MALDI-TOF 
mass-spectrometry. In the first case, the total amount of the dye (OF+CF) had to be 
considered, since a small amount of the CF (ca. 5-10%) was present. The latter was possible 
formed during purification and handling of the bioconjugate solutions. As is the standard 
procedure, we assumed for the calculations that all absorption coefficients (for both isomers) 
in PBS are the same for the free dyes and their bioconjugates. Therefore, this method might 
introduce a considerable error in the DOLAbs value calculated. Thus, an independent 
measurement of the DOL was performed by mass-spectrometry. Unfortunately, the values 
determined by this second method also have some errors, due to the lack of a calibration 
standard in the high-mass region (150 kDa) of the antibodies. The DOLMALDI was calculated 
from the difference of the mass measured for the unlabeled antibody (the exact same batch 
was used; a few microliters were saved for MALDI measurements prior to the labeling) and 
the corresponding bioconjugate. The results (DOLAbs and DLMALDI) obtained for the 
preparation of different bioconjugates are presented in Table S1. The differences encountered 
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within the two methods are in the range as previously reported ones.[6] Comparing both 
labeling protocols, we can estimate that the efficiency of the “in situ” labeling (3.3.2) yield 
approximately a ca. 40-50% lower efficiency than the protocol with the priory activated 
(NHS) dye (3.3.1). 
Table S1. Degree of labeling (DOL) of diarylethene-bioconjugates prepared from compounds 1, 2 and 
IgG as determined by UV-Vis spectroscopy and/or by MALDI-TOF mass-spectrometry.  
(a) the mass of the protein was 2 mg in all cases; (b) determined from MALDI-TOF mass-spectrometry; (c) the unlabeled 
secondary antibody (IgG) of the same protein batch (few micrograms were separated before the dye addition); (d) compound 
8 was used (see protocol 3.3.1); (e) biexponential decays (relative amplitudes are given in parenthesis); (f) compound 2 was 
used (see protocol 3.3.2). 
4. Immunolabeling and fluorescence imaging   
4.1 Immunolabeling protocol 
Vero cell samples cells were grown on standard cover slips and then fixed with previously 
cooled (-20 °C) methanol for 5 min, and blocked with 5% (w/v) BSA in PBS pH = 7.4 
(blocking buffer). Then the cells were incubated with an anti-α-tubulin mouse primary 
antibody (Sigma Aldrich, St. Louis, MO, USA) at r.t. for 1 h, followed by three washing steps 
of 5 min each with blocking buffer. The cells were then incubated at r.t. for 1 h with our 
labeled bioconjugates from Table S1 (typical dilutions of 1:50 to 1:100 from the purified 
bioconjugate) and washed again (5 min each step) three times with blocking buffer and finally 
with the mounting media (PBS, pH 7.4). The samples were mounted in concave microscopy 
slides and sealed with a silicone resin (Picodent Twinsil) to prevent leakage. 
4.2 Confocal images with two representative bioconjugates, BC1B and 
BC2A 
Standard confocal imaging was performed in a commercial Leica TCS SP5 confocal 
microscope. Images (Figure S1) were recorded with 488 nm excitation, after a short (ca. 1 s) 
and low- intensity wide-field pre-activation with 366 nm light, from the mercury lamp. 
Detection was collected between 510 and 600 nm. A fading of the signal was observed after 
repeated scanning of the same area, due to the isomerization (CFOF) induced by the 
excitation light (a process competing with fluorescence emission of the probe). The signal can 









ABc --- --- 146007  93 --- --- --- 
BC1A 1d 0.20 150108  288 8.1 4.6  0.3 2.3 (84 %) / 1.0 (16 %)e 
BC1B 1d 0.10 148300  271 5.2 2.6  0.3 2.3 (80 %) / 1.0 (20 %)e 
BC2A 2f 0.20 149659  126 5.3 2.7  0.1 2.05  0.5 
BC2B 2f 0.10 147962  277 4.0 1.5  0.2 2.01  0.5 
BC2C 2f 0.05 146740  301 2.4 0.5  0.2 2.00  0.5 
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be recovered with another pre-activation pulse, and thus further imaging of the same area can 
be repeated several times. 
 
Figure S1. Confocal images of immunolabeled cytoskeletal protein tubulin in mammalian cells (Vero). Scale 
bars: 10 m. 
4.3 Fluorescence spectroscopy and RESOLFT imaging  
The pump-probe fluorescence measurements were performed on a custom build confocal 
microscope with an additional widefield illumination (Figure S2). The intensities of this 
widefield illumination given in the main text were calculated from the observed illumination 
FWHMs of the corresponding laser spots on a fluorescent sample and their measured power 
in front of the sample (I = Pmeas / (π∙FWHM2/4)). The RESOLFT images were acquired with a 
modified 1C RESOLFT QUAD Scanning microscope (Abberior Instruments, Göttingen, 
Germany). The intensities of the different illumination beams were calculated from the 
measured size of their point spread functions (PSFs) of fluorescent beads and their measured 
power in the back focal plane of the objective (I = Pmeas / (π∙FWHM2/4). For the intensity 
calculations of the doughnut-shaped beam it was taken into account, that the illuminated area 
is about 2.3 times bigger than by a corresponding Gaussian-shaped beam. The transmission of 
the 488 nm light through the objective was assumed to be 85% and the transmission of the 
355 nm light to be 50%. 
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Figure S2. Outline of the microscope setup for fluorescence lifetime and photo-switching measurements. 
A confocal illumination and detection was provided via the base port of a commercial 
microscope stand (DM IRBE, Leica Microsystems) and a 100× oil-immersion objective with 
1.4 NA (HCX PL APO 100×/1.4-0.7 Oil CS, Leica). A broad-band supercontinuum laser 
(SuperK Extreme EXB-6, NKT Photonics) and an acousto-optic tunable filter (AOTFnC-VIS-
TN head with MDS8C-B66-22-80.153 driver, AA OptoElectronic) provided pulsed excitation 
light (40 MHz repetition rate, ~100ps pulse width) at selectable wavelengths with ~3nm 
bandwidth and modulated power. A polarization-maintaining single-mode fiber (PM460-HP, 
Thorlabs) cleaned up the spatial mode profile and a bandpass filter F1 (Z488/10x, Chroma) the 
spectrum. The beam was collimated by an achromatic lens L1 (f1 = 10 mm, AC080-010-A, 
Thorlabs). 
Two polarizing beam splitters PBS (PBS251, Thorlabs), an achromatic half-wavelength 
retarder plate /2 (AHWP05M-600, Thorlabs) and a Faraday rotator (711A, Conoptics, used 
without polarizers) provided a directional broad-band beam splitting for the excitation and 
fluorescence light. The UV and blue light were fed separately via dichroic mirrors D1 and D3 
(Z488RDC, Chroma) because the Faraday rotator showed poor performance at wavelengths  
< 500 nm. A power-modulated UV laser diode (405 nm wavelength, 30 mW, BCL-30-405-S, 
CrystaLaser), a polarization-maintaining single-mode fiber (P5-405BPM, Thorlabs), an 
achromatic lens L2 (f2 = 30 mm, AC254-030-A, Thorlabs) and a clean-up filter F2 (Z405/10x, 
Chroma) provided a clean laser beam at 405 nm wavelength for switching. The illumination 
beams were combined by a dichroic mirror D2 (Z405RDC, Chroma) and their beam diameters 
were magnified 4× by an achromatic lens L3 (f3 = 50 mm, AC254-050-A, Thorlabs) and the 
microscope tube lens (ft = 200 mm). The confocal illumination polarization was circularized 
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The fluorescence emission was selected by band-pass filters F5 (FF03-525/50, Semrock), 
focused with achromatic lenses L5 (f5 = 30 mm, AC254-030-A, Thorlabs) into step-index 
multimode fibers (core Ø25 m, M67L01, Thorlabs) and detected by avalanche photo-diodes 
APDs (PD-050-CTD-FC, MicroPhotonDevices). The detected photon events were recorded 
as photon streams with a TimeHarp260 NANO board (PicoQuant) and analyzed for 
fluorescence lifetime. Simultaneously, a hardware correlator (Flex02-08D/C, Correlator.com) 
was used for real-time monitoring of the detection count rates and for fluorescence correlation 
spectroscopy of fluorophore solutions, useful for quickly aligning the setup. 
Piezo scanners allowed to position the sample and to focus on fluorescently labeled features. 
For finding cells quickly, a widefield illumination was set up. Laser diodes provided light at 
491 nm wavelength (50 mW cw, Calypso 50, Cobolt) and 375 nm wavelength (20 mW cw, 
switchable up to 100 kHz, FBB-375-020-FS-E-1-0, RGBLase). An acousto-optic tunable 
filter AOTF (AOTFnC-TN head with MOD4C-VIS driver, AA OptoElectronic) was used to 
modulate the power of the 491 nm light. Neutral density filters F3 adjusted the power and a 
band-pass filter F4 (Z375/10x, Chroma) cleaned up the spectrum of the 375 nm laser beam. A 
dichroic mirror D4 (Z375RDC, Chroma) combined the laser beams. A clean-up filter was not 
required for the 491 nm laser beam. An illumination field of 15–20 m diameter was obtained 
by focusing the beams with an achromatic lens L4 (f4 = 45 mm, AC254-045-A, Thorlabs). 
This widefield illumination allowed to characterize photo-switching of moving fluorophores 
because the fluorophores were switched synchronously regardless of their microscopic 
motion. 
 
Figure S3. Fluorescence emission of cells immunolabeled with dyes 1 (A) and 2 (C) showing the on/off 
switching cycles upon irradiation with the light pulse sequence mentioned in the main text (gray bursts). The red 
line indicates the maximum fluorescence signal detected within a switching cycle, while the black line displays 
the overall fluorescence gained per cycle. Both plots were normalized to their maximum value. B and D show 
one switching cycle as the mean value of 200 cycles (black dots) of dye 1 and 2, respectively. The bi-exponential 
fit used to determine the switching kinetics is shown as red solid line. All measurements were taken with 20 µs 
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Figure S4. Confocal and corresponding RESOLFT image of the whole fixed Vero cells immunostained with 
primary antibodies against α-Tubulin and with the diarylethene 1 attached to the secondary antibodies. All 
images show raw data and were acquired with 30 nm pixel size. Scale bar: 1 µm. The following pulse pattern 
was used to acquire the RESOLFT image: 10 µs of 355 nm light (0.63 kW/cm2), 200 µs illumination break, 7 ms 
of doughnut-shaped 488 nm beam(10.6 kW/cm2), 80 µs of a Gaussian shaped 488 nm light beam (9.7 kW/cm2) 
to probe the remaining fluorescence. The same pulse sequence was applied to record the confocal images but the 
off-switching with the doughnut-shaped beam was omitted. The line profiles A–C (averaged over ten adjacent 
lines) display the regions indicated in the images. The data (dots) was fitted with a Lorentzian function (solid 
line) for the RESOLFT (red) and the confocal (blue) image. The FWHM was determined on the fits A, B and C. 
 
Figure S5. Confocal and corresponding RESOLFT image of the whole fixed Vero cells immunostained with 
primary antibodies against Nucleoporin 153 (Nup153) and with the diarylethene 2 attached to the secondary 
antibodies. All images show raw data and were acquired with 35 nm pixel size. The color –bars indicate the 
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5. NMR spectra of 3,5-disubstituted phenyl boronates 
Tetra-tert-butyl 5-bromobenzene-1,3-bis-(N-iminodiacetate) (3) 
1H NMR spectrum in CDCl3 (400 MHz) * peaks assigned to residual solvent peak (EtOAc) 
 





* * * 
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Tetra-tert-butyl benzeneboronic acid pinacol ester 3,5-bis-(N-iminodiacetate) (4)
  
1H NMR spectrum in CDCl3 (400 MHz) * peak assigned to residual B(pin)2 
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6. NMR, ESI-MS and RP-HPLC spectra of diarylethene 
derivatives 
“Tetra-aldehyde” (5) 
1H NMR spectrum in CDCl3 (400 MHz) 
 
13C NMR spectrum in CDCl3 (126 MHz) 
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19F NMR spectrum in CDCl3 (376 MHz) 
 




Carboxylated photoswitchable diarylethenes for biolabeling and super-resolution fluorescence microscopy Page 23 
“Tetra-tert-butyl ester” (6) 
1H NMR spectrum in CDCl3 (400 MHz) 
 
13C NMR spectrum in CDCl3 (101 MHz) 
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19F NMR spectrum in CDCl3 (376 MHz) 
 




Carboxylated photoswitchable diarylethenes for biolabeling and super-resolution fluorescence microscopy Page 25 
“Tetra-acid” (1) 
1H NMR spectrum in CDCl3/CF3COOD (500 MHz)  
 
13C NMR spectrum in CDCl3/CF3COOD (126 MHz) 
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19F NMR spectrum in CDCl3/CF3COOD (471 MHz) 
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RP-HPLC elution profile (system A) 
 
mono NHS ester (8) 
HRMS-ESI mass spectra (negative mode) 
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RP-HPLC elution profile (system B) 
 
“Octa-acid” tert-butyl ester (7) 
1H NMR spectrum in CDCl3 (500 MHz)  
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13C NMR spectrum in CDCl3 (126 MHz) 
 
19F NMR spectrum in CDCl3 (376 MHz) 
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ESI mass spectra (positive mode) 
 
“Octa-acid” (2) 
1H NMR spectrum in DMF-d7 (500 MHz)  
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13C NMR spectrum in DMF-d7 (126 MHz) * peak assigned to residual triethyl 
 amine left after lyophilisation 
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HRMS-ESI mass spectra (negative mode) 
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 “Tetra-acid” (1-CF)  
1H NMR spectrum in DMF-d7 (400 MHz) * residual CH3CN and solvents 
 
“Octa-acid” (2-CF) 
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7. Absorption/Emission spectra of dyes 1 and 2 and their 
bioconjugates in PBS and MeOH 
 
 
Figure S6. Absorption and emission spectra of free dyes 1 and 2 in MeOH and PBS (pH = 7.4). Absorption 
coefficients (left axes) of the open (black lines) and closed (red lines) and fluorescence emission (right axes). 
Main properties in methanol for both compounds are summarized in Table S2 (see below). 
 
Table S2. Photophysical properties of free dyes 1 and 2 in methanol. 
  1 2 
max abs [nm] /  [M-1cm-1] OF[a] 330 / 12400 331 / 16000 
max abs [nm] /  [M-1cm-1] CF 449 / 35000 448 / 44500 
max em [nm] CF 528; 556 523; 552 
fl [b] CF 0.69 0.70 
 [ns] CF 2.52 ± 0.05 2.54 ± 0.05 
OFCF [c]  0.29 ± 0.04 0.24 ± 0.04 
CFOF [d]  2.810-3 ± 310-4 2.610-3 ± 310-4 
[a] only the peak at the longest wavelength is reported; [b] fluorescein in 0.1 M NaOH 
(emission efficiency 0.79) was used as standard; [c] at 365 nm; [d] at 470 nm. 
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Figure S7. Absorption and emission spectra of two representative bioconjugates of 1 and 2 in PBS (pH = 7.4): 
changes observed upon irradiation. Diluted samples were placed in a 1 cm path quartz cuvette, and irradiated 
with 365 nm light or 470 nm light from collimated LEDs (M365L2 and M470L3, Thorlabs Inc., Germany) under 
continuous vigorous stirring. Typical irradiation light powers used were around 10-20 mW. Absorption and 
emission spectra were recorded after each irradiation step. Irradiation of bioconjugates of compounds 1 (BC1B) 
and 2 (BC2A) with a similar degree of labeling (DOLAbs  5), in diluted PBS (pH = 7.4) solutions. Absorption 
(left axes) and fluoresce emission (right axes) changes upon irradiation with UV and visible light.  
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